MINNEAPOLIS, Feb. 24, 2014 /PRNewswire/ -- Skyline Medical (OTCQB: SKLN) has assembled a dynamic team of sales leaders to build out a larger U.S. sales force in response to increasing demand for its STREAMWAY System a revolutionary, FDA-approved system for automated, direct-to-drain medical fluid disposal.
Regional managers were recently hired to oversee sales activities in the company’s seven sales regions: the Great Lakes, Mid-Atlantic, Midwest, Northeast, Southeast, Southwest and West.
“As more and more healthcare facilities seek to move away from antiquated, high-risk fluid disposal methods, we’ve seen increasing demand for our safer, more efficient and environmentally sound STREAMWAY System,” said Josh Kornberg, CEO of Skyline Medical.
“We searched long and hard to identify, recruit and hire top industry sales people who could help us meet growing demand and make STREAMWAY the new standard for waste fluid management,” he added. “These individuals bring extensive experience in capital equipment sales, as well as solid relationships with hospital decision makers in their respective regions. Their expertise and leadership will help us meet current demand, uncover new opportunities and close sales to grow the company.
“With several high profile medical trade shows beginning in March, the hiring of this high-powered sales team is timely,” Kornberg noted. “We expect to generate a substantial number of new sales opportunities by demonstrating our STREAMWAY System at the Association of PeriOperative Registered Nurses (AORN), the Society of Interventional Radiology (SIR) and the Ambulatory Surgery Center Association (ASCA) events. Through this new, expanded sales presence we are better positioned than ever before to present our enhanced STREAMWAY at these important and influential industry trade shows,” concluded Kornberg.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods which require hand carrying and emptying filled-fluid canisters present an exposure risk and potential liability. Skyline Medical’s STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with Occupational State and Health Association (OSHA) and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit: www.skylinemedical.com.
Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $2.7 million in debts, liabilities and cash obligations that become due over the next twelve months; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company’s financial position. See the Company’s most recent Annual Report on Form 10-K, as amended, and subsequent 8-K and other filings at www.sec.gov.
Skyline Investor Relations Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
skyline@kcsa.com
SOURCE Skyline Medical Inc.
Help employers find you! Check out all the jobs and post your resume.
